US Broker Ratings

BeOne Medicines Ltd. (ONC) Stock Analysis: A 52.64% Potential Upside Beckons Investors

Investors keen on the biotechnology sector might find BeOne Medicines Ltd. (NASDAQ: ONC) a compelling opportunity. With a market cap of $28.03 billion, this Switzerland-based oncology company is making waves..

Cencora, Inc. (COR) Stock Analysis: Understanding Its 28.97% Upside Potential

Cencora, Inc. (NYSE: COR), a major player in the healthcare sector, is attracting significant investor attention due to its compelling 28.97% potential upside based on current analyst ratings. As a..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 52.84% Potential Upside for Investors

Universal Health Services, Inc. (NYSE: UHS), a stalwart in the healthcare sector, is catching the attention of investors with its strong market presence and promising growth potential. Operating primarily in..

Gilead Sciences, Inc. (GILD) Investor Outlook: 27% Upside Potential and Robust Dividend Yield

Gilead Sciences, Inc. (NASDAQ: GILD) presents a compelling investment case for those seeking stability in the healthcare sector, coupled with promising growth prospects. With a market capitalization of $153.66 billion,..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 39% Potential Upside in the Healthcare Sector

For investors looking to deepen their portfolios within the healthcare sector, Stevanato Group S.p.A. (NYSE: STVN) presents a compelling case. With a market capitalization of $4.79 billion, this Italy-based company..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth

TG Therapeutics, Inc. (NASDAQ: TGTX) is making waves in the biotechnology sector, capturing investor attention with its innovative treatments for B-cell mediated diseases. With a market cap of $8.15 billion,..

Corcept Therapeutics (CORT) Stock Analysis: A Promising 10.12% Upside in Biotech

Corcept Therapeutics Incorporated (NASDAQ: CORT) emerges as a compelling player in the biotechnology sector, currently commanding a market capitalization of $8.58 billion. Specializing in the development of therapies for severe..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 14.82% Upside Potential Amid Growing Revenue

Align Technology, Inc. (NASDAQ: ALGN) stands out in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $13.04 billion, the company is a..

Dr. Reddy’s Laboratories Ltd (RDY): Analyst Consensus and Growth Potential Amidst Market Volatility

In the ever-evolving landscape of the pharmaceutical industry, Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a formidable player, offering a diverse range of products across global markets. With a..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a 106% Upside Potential in the Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN) is a burgeoning player in the biotechnology industry, with a strategic focus on developing innovative cell therapies to combat oncology and other serious diseases. Headquartered..

Bausch + Lomb Corporation (BLCO) Investor Outlook: Unlocking a 20% Upside Potential

Bausch + Lomb Corporation (NYSE: BLCO), a renowned name in the healthcare sector, stands prominently in the medical instruments and supplies industry. With a market capitalization of $5.3 billion, this..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a 17.12% Potential Upside with Solid Dividend Yield

Investors with a keen eye on the healthcare sector may find AbbVie Inc. (NYSE: ABBV) an intriguing option, as this pharma giant continues to showcase robust growth prospects and a..

Chemed Corp (CHE) Stock Analysis: Evaluating Its Potential Upside for Healthcare Investors

Chemed Corp (NYSE: CHE) operates in the healthcare sector, specifically within the medical care facilities industry, and has carved out a unique position through its two primary business segments: VITAS..

Regeneron Pharmaceuticals (REGN) Stock Analysis: Unpacking Its 36.62% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a prominent player in the biotechnology industry, is capturing the attention of investors with its robust pipeline and promising growth prospects. With a market capitalization..

Bruker Corporation (BRKR) Stock Analysis: Navigating Promising Terrain in Healthcare with Caution Due to Valuation Concerns

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, specializes in the medical devices industry. With a market capitalization of $8.71 billion, Bruker is a significant entity within..

ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking the 111.79% Potential Upside for Savvy Investors

Investors eyeing the biotechnology sector might find ADMA Biologics Inc (NASDAQ: ADMA) an intriguing prospect. With its current market capitalization sitting at an impressive $1.93 billion, ADMA is a notable..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A Biotech Gem with a 34% Upside Potential

Investors keeping a keen eye on the biotechnology sector may find Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) an intriguing opportunity. With a current market cap of $11.66 billion, this biopharmaceutical company..

Ascendis Pharma A/S (ASND) Stock Analysis: Unveiling a 27% Upside Potential with Robust Growth Metrics

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biopharmaceutical innovator, is capturing the attention of investors with its promising upside potential and impressive growth metrics. As a key player in the..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: A Healthcare Heavyweight with a 5.16% Potential Upside

Bio-Rad Laboratories, Inc. (NYSE: BIO) is a formidable player in the healthcare sector, with a specialized focus on medical devices. With a market capitalization of $7.56 billion, Bio-Rad has carved..

West Pharmaceutical Services, Inc. (WST): Strong Buy Ratings and 9.4% Potential Upside Signal Promising Investment Outlook

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $23.17 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds